Artificial intelligence has moved from the laboratory into the everyday decisions that shape children’s lives, and a new perspective in Pediatric Research asks a question that is becoming impossible to ignore: as machines learn more about medicine, how well are humans learning to govern them? In “Machines are learning: are we?”, D. Keller, writing on behalf of the Pediatric Policy Council, places machine learning within the rapidly changing landscape of pediatric care. The article’s central concern is not whether algorithms will become more powerful, but whether clinicians, families, researchers and policymakers can ensure that this power is used safely, transparently and fairly. The question is especially urgent in pediatrics, where patients are still growing, medical data change over time and decisions made during childhood can influence an entire lifetime.
Machine learning is not a single technology but a broad family of computational methods that identify patterns in data and use those patterns to generate predictions or recommendations. In supervised learning, an algorithm is trained on examples that include an outcome, such as whether a child developed a complication after treatment. The system adjusts millions of internal parameters until its predictions closely match the examples it has seen. It is then evaluated on data that were not used during training. More complex systems, including deep neural networks, can process medical images, electronic health records, genetic information or streams of physiological measurements. Their apparent intelligence, however, comes from statistical relationships rather than human-like understanding. An algorithm may recognize combinations of signals associated with risk without knowing why those signals matter or whether the relationship will remain valid in a different hospital or population.
That distinction has major consequences for pediatric medicine. Children are not simply smaller adults. Their organs, immune systems, metabolism and patterns of disease change with age, and the meaning of a measurement can differ dramatically between a premature infant, a school-aged child and an adolescent. A model trained primarily on adult records may produce confident but unreliable predictions when applied to children. Even a pediatric model can become outdated as clinical practices, diagnostic equipment and population characteristics change. This phenomenon, known as distribution shift, occurs when the data encountered in real-world use differ from the data used to develop the system. Continuous monitoring is therefore essential. Accuracy at the moment of publication cannot guarantee safety years later.
The data required to train these systems also raise difficult questions. Pediatric health information is highly sensitive because it can reveal developmental, genetic, behavioral and family-related details. Children usually cannot provide the same form of legal consent as adults, and their ability to understand future data uses evolves as they mature. Information collected for one purpose may later be reused to develop an algorithm, shared across institutions or combined with data from wearable devices and online services. De-identification can reduce privacy risks, but removing names does not make data automatically anonymous. Rare diseases, unusual genetic patterns and small communities can make individuals easier to re-identify. Effective governance must address who controls the data, how long they are retained, how families are informed and what rights children have when they become adults.
Bias is another technical problem with direct clinical consequences. An algorithm learns from the examples it receives, and medical datasets often reflect unequal access to care. If some communities are underrepresented, the system may perform well for the majority while missing disease in groups whose symptoms were historically overlooked or whose records are less complete. Bias can enter through the choice of outcome, the way labels are assigned, the instruments used to collect measurements or the decision to exclude incomplete records. Developers can measure performance across demographic groups using metrics such as sensitivity, specificity, false-positive rates and calibration. Calibration is particularly important: among patients assigned a predicted risk of 20 percent, approximately one in five should experience the outcome. A model that is accurate on average but poorly calibrated for a particular group can still cause serious harm.
The language used to describe algorithmic performance can also encourage misunderstanding. An area under the receiver operating characteristic curve, often abbreviated AUC, summarizes how well a model ranks patients with and without a condition across thresholds. It does not show whether using the model improves outcomes, reduces unnecessary treatment or works in a busy clinic. High predictive performance in a retrospective dataset may collapse during prospective deployment, when clinicians respond to the prediction and alter the very outcomes being measured. A model may also identify correlation rather than causation. If children who receive a particular test appear to have worse outcomes, the algorithm could learn that the test is a warning signal without recognizing that physicians ordered it precisely because those children were already critically ill.
For that reason, the most responsible systems will need more than impressive demonstrations. They require external validation in multiple settings, prospective studies and evaluation of patient outcomes after implementation. Clinicians should know the intended use of a tool, its limitations, its uncertainty and the population in which it was tested. Explainability methods can show which variables influenced a prediction, although a visually persuasive explanation is not necessarily a proof that the model is reasoning correctly. Human oversight remains essential, but it cannot be treated as a magic safeguard. Under time pressure, clinicians may over-trust automated recommendations, a phenomenon known as automation bias. Safe design must make it easy to question a prediction, document disagreement and escalate uncertain cases rather than quietly turning an algorithm into an unaccountable authority.
The policy challenge becomes even more complicated when machine learning moves beyond diagnosis. Algorithms may assist with triage, hospital scheduling, medication dosing, developmental assessment, mental-health screening and the allocation of scarce services. Each application carries a different balance of benefit and risk. A system that flags a possible medication error may function as a valuable second check, while a tool that predicts future behavior or educational performance could stigmatize a child long before any condition is confirmed. Pediatric policy must therefore distinguish between systems that support professional judgment and systems that effectively make decisions about access, treatment or opportunity. Families should be able to understand when an algorithm is involved and should have meaningful avenues for appeal when an automated recommendation affects care.
The perspective by Keller and the Pediatric Policy Council arrives as machine learning becomes increasingly visible to the public, sometimes through dramatic claims that obscure the slower work of validation and oversight. The most important question is not whether machines can learn patterns, but whether institutions can learn from their mistakes quickly enough to protect children. That means building diverse datasets, testing systems across ages and populations, publishing negative results, auditing performance after deployment and involving young people and families in decisions about data use. It also means educating health professionals so that technical fluency becomes part of clinical competence. Artificial intelligence may eventually help clinicians detect illness earlier, personalize treatment and manage overwhelming quantities of information. But its legitimacy in pediatrics will depend on a principle more fundamental than novelty: every computational prediction must remain accountable to the child whose life it may influence.
Subject of Research: Machine learning, artificial intelligence, pediatric medicine, and policy considerations for the safe and equitable use of data-driven technologies in children’s healthcare.
Article Title: “Machines are learning: are we?”
Article References: Keller, D., On behalf of the Pediatric Policy Council. Machines are learning: are we? Pediatr Res (2026). https://doi.org/10.1038/s41390-026-05364-y
Image Credits: AI Generated
DOI: https://doi.org/10.1038/s41390-026-05364-y
Keywords: artificial intelligence, machine learning, pediatrics, children’s health, medical ethics, health policy, algorithmic bias, data privacy, clinical decision support
